Literature DB >> 23735534

Immune responses to infection with H5N1 influenza virus.

Guus F Rimmelzwaan1, Jacqueline M Katz.   

Abstract

Influenza A H5N1 viruses remain a substantial threat to global public health. In particular, the expanding genetic diversity of H5N1 viruses and the associated risk for human adaptation underscore the importance of better understanding host immune responses that may protect against disease or infection. Although much emphasis has been placed on investigating early virus-host interactions and the induction of innate immune responses, little is known of the consequent adaptive immune response to H5N1 virus infection. In this review, we describe the H5N1 virus-specific and cross-reactive antibody and T cell responses in humans and animal models. Data from limited studies suggest that although initially robust, there is substantial waning of the serum antibody responses in survivors of H5N1 virus infection. Characterization of monoclonal antibodies generated from memory B cells of survivors of H5N1 virus infection has provided an understanding of the fine specificity of the human antibody response to H5N1 virus infection and identified strategies for immunotherapy. Human T cell responses induced by infection with seasonal influenza viruses are directed to relatively conserved internal proteins and cross-react with the H5N1 subtype. A role for T cell-based heterosubtypic immunity against H5N1 viruses is suggested in animal studies. Further studies on adaptive immune responses to H5N1 virus infection in both humans and animals are needed to inform the design of optimal immunological treatment and prevention modalities. Published by Elsevier B.V.

Entities:  

Keywords:  Immune response; Infection; Influenza A H5N1 virus

Mesh:

Substances:

Year:  2013        PMID: 23735534      PMCID: PMC8996553          DOI: 10.1016/j.virusres.2013.05.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  102 in total

1.  Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2011.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-03-30

2.  Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

Authors:  T Rowe; R A Abernathy; J Hu-Primmer; W W Thompson; X Lu; W Lim; K Fukuda; N J Cox; J M Katz
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice.

Authors:  Eduardo O'Neill; Scott L Krauss; Janice M Riberdy; Robert G Webster; David L Woodland
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

4.  Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus.

Authors:  Philippe Buchy; Sirenda Vong; Simon Chu; Jean-Michel Garcia; Tran Tinh Hien; Vo Minh Hien; Mey Channa; Do Quang Ha; Nguyen Van Vinh Chau; Cameron Simmons; Jeremy J Farrar; Malik Peiris; Menno D de Jong
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

5.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

6.  Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.

Authors:  Hua Wang; Zijian Feng; Yuelong Shu; Hongjie Yu; Lei Zhou; Rongqiang Zu; Yang Huai; Jie Dong; Changjun Bao; Leying Wen; Hong Wang; Peng Yang; Wei Zhao; Libo Dong; Minghao Zhou; Qiaohong Liao; Haitao Yang; Min Wang; Xiaojun Lu; Zhiyang Shi; Wei Wang; Ling Gu; Fengcai Zhu; Qun Li; Weidong Yin; Weizhong Yang; Dexin Li; Timothy M Uyeki; Yu Wang
Journal:  Lancet       Date:  2008-04-08       Impact factor: 79.321

Review 7.  Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review.

Authors:  Maria D Van Kerkhove; Elizabeth Mumford; Anthony W Mounts; Joseph Bresee; Sowath Ly; Carolyn B Bridges; Joachim Otte
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

8.  Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.

Authors:  Yasuko Hatta; Karen Hershberger; Kyoko Shinya; Sean C Proll; Richard R Dubielzig; Masato Hatta; Michael G Katze; Yoshihiro Kawaoka; M Suresh
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

Authors:  Cameron P Simmons; Nadia L Bernasconi; Amorsolo L Suguitan; Kimberly Mills; Jerrold M Ward; Nguyen Van Vinh Chau; Tran Tinh Hien; Federica Sallusto; Do Quang Ha; Jeremy Farrar; Menno D de Jong; Antonio Lanzavecchia; Kanta Subbarao
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

10.  A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Authors:  Nigel J Temperton; Katja Hoschler; Diane Major; Carolyn Nicolson; Ruth Manvell; Vo Minh Hien; Do Quang Ha; Menno de Jong; Maria Zambon; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

View more
  5 in total

1.  Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice.

Authors:  Mable Hagan; Charlene Ranadheera; Jonathan Audet; Jocelyn Morin; Anders Leung; Darwyn Kobasa
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

2.  T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects.

Authors:  Pirom Noisumdaeng; Thaneeya Roytrakul; Jarunee Prasertsopon; Phisanu Pooruk; Hatairat Lerdsamran; Susan Assanasen; Rungrueng Kitphati; Prasert Auewarakul; Pilaipan Puthavathana
Journal:  PeerJ       Date:  2021-03-10       Impact factor: 2.984

3.  Severe Infection With Avian Influenza A Virus is Associated With Delayed Immune Recovery in Survivors.

Authors:  Jianing Chen; Guangying Cui; Chong Lu; Yulong Ding; Hainv Gao; Yixin Zhu; Yingfeng Wei; Lin Wang; Toshimitsu Uede; Lanjuan Li; Hongyan Diao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

4.  MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.

Authors:  Vineet D Menachery; Alexandra Schäfer; Kristin E Burnum-Johnson; Hugh D Mitchell; Amie J Eisfeld; Kevin B Walters; Carrie D Nicora; Samuel O Purvine; Cameron P Casey; Matthew E Monroe; Karl K Weitz; Kelly G Stratton; Bobbie-Jo M Webb-Robertson; Lisa E Gralinski; Thomas O Metz; Richard D Smith; Katrina M Waters; Amy C Sims; Yoshihiro Kawaoka; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 5.  A Review of DNA Vaccines Against Influenza.

Authors:  Leo Yi Yang Lee; Leonard Izzard; Aeron C Hurt
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.